Premium
Programmed death‐ligand 1 testing in patients with non–small cell lung cancer: Ready for prime time?
Author(s) -
Gainor Justin F.
Publication year - 2017
Publication title -
cancer cytopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.29
H-Index - 57
eISSN - 1934-6638
pISSN - 1934-662X
DOI - 10.1002/cncy.21882
Subject(s) - medicine , immunotherapy , cancer , lung cancer , epidermal growth factor receptor , anaplastic lymphoma kinase , targeted therapy , immunology , immune system , cancer research , cancer immunotherapy , monoclonal antibody , oncology , antibody , malignant pleural effusion
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom